Crohn's Disease and Colitis Trial, By Invitation NCT07257588 Sponsor: Xijing Hospital of Digestive Diseases Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, By Invitation

NCT07257588
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A diagnosis of ulcerative colitis must have been confirmed according to the 2018 national consensus guidelines on the diagnosis and treatment of inflammatory bowel disease.
  • A diagnosis of acute severe ulcerative colitis must be present, meaning 6 or more episodes of bloody stools per day plus at least one of the following: a heart rate of 90 beats per minute or more, a body temperature above 37.8°C, a hemoglobin level below 105g/L, or an erythrocyte sedimentation rate (a blood test measuring inflammation) above 30mm/h.
  • People aged 18 years or older.
  • People who are able and willing to follow the study procedures and have signed and dated a written consent form agreeing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who may need immediate surgery.
  • People who are pregnant or currently breastfeeding.
  • People with a score below 6 on a specific Eustachian tube measurement test (confirm with trial site).
  • People who have a lung bulla (an air-filled blister on the lung) larger than 2 cm found near the top of the lung or near the lung's outer lining on a chest scan.
  • People with severe liver or kidney problems, heart failure, or other serious conditions affecting the whole body.
  • People with a history of drug or alcohol misuse, people who are current smokers who have not quit, people with a mental health condition or a history of poor compliance with medical instructions, or people with known conditions affecting the immune system (including HIV), the blood, or cancer-related diseases.
  • People who have withdrawn their consent to take part.
  • People who have taken part in another clinical trial within the 3 months before the screening visit.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Xijing Hospital of Digestive Diseases
Registry
ClinicalTrials.gov
Start date
30 September 2024
Est. completion
31 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Clinical response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov